Comparative effects of Aβ(1-42)-Al complex from rat and human amyloid on rat endothelial cell cultures

Journal of Alzheimer's Disease

Volumn 11, Issue 1, 2007, Pages 33-44

  Drago, Denise ^a   Folin, Marcella ^b   Baiguera, Silvia ^b   Tognon, Giuseppe ^a   Ricchelli, Fernanda ^a   Zatta, Paolo ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Aluminum; Alzheimer; Amyloid; Blood brain barrier; Endothelial cells; Metal ions

Indexed keywords

ALUMINUM; AMYLOID BETA PROTEIN[1-42]; AMYLOID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; MALE; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BRAIN; DRUG EFFECT; ELECTRON MICROSCOPY; HUMAN; METABOLISM; MICROCIRCULATION; NEUROFIBRILLARY TANGLE; OXIDATION REDUCTION REACTION; PATHOLOGY; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ALUMINUM; AMYLOID; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; MALE; MICROCIRCULATION; MICROSCOPY, ELECTRON; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROFIBRILLARY TANGLES; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33847757861     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2007-11107     Document Type: Article

References (48)

1. W.A. Banks, A.J. Kastin and P. Zatta, The blood-brain barrier in aluminium toxicity and Alzheimer's disease, in: Nonneuronal cells in Alzheimer's disease, P. Zatta and M. Nicolini, eds, World Scientific, Singapore, 1995, pp. 1-12.
2. S. Gandy, The role of cerebral amyloid β accumulation in common forms of Alzheimer disease, J Clin Inv 115 (2005), 1121-1129.
3. M.M. Esiri, G.K. Wilcock and H.J. Morris, Neuropathological assessment of the lesions of significance in vascular dementia, J Neurol Neurosurg Psychiatry 63 (1997), 749-753.
4. H.V. Vinters, W.G. Ellis, C. Zarow, B.W. Zaias, W.J. Jagust, W.J. Mack and H.C. Chui, Neuropathologic substrates of ischemic vascular dementia, Exp Neurol 59 (2000), 931-945.
5. C. Iadecola, Cerebrovascular effects of amyloid-β peptides: mechanisms and implications for Alzheimer's dementia, Cell Molec Neurobiol 23 (2003), 681-689.
6. T. Thomas, G. Thomas, C. McLendon, T. Sutton and M. Mullan, beta-Amyloid-mediated vasoactivity and vascular endothelial damage, Nature 380 (1996), 108-111.
7. I.G. Farkas, A. Czigner, E. Farkas, E. Dobo, K. Soos, B. Penke, V. Endresz and A. Mihaly, Beta-amyloid peptideinduced blood-brain barrier disruption facilitates T-cell entry into the rat brain, Acta Histochem 105 (2003), 115-125.
8. M. Folin, S. Baiguera, M. Tommasini, D. Guidolin, M.T. Conconi, E. De Carlo, P.P. Parnigotto and G.G. Nussdorfer, Effects of β-Amyloid on rat neuromicrovascular endothelial cells cultured in vitro, Int J Mol Med 15 (2005), 929-935.
9. P. Grammas, M. Yamada and B. Zlokovic, The cerebromicrovasculature: a key player in the pathogenesis of Alzheimer's disease, J Alzheimer Dis 4 (2002), 217-223.
10. M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell and W.R. Markesbery, Copper, iron and zinc in Alzheimer's disease senile plaques, J Neurol Sci 158 (1998), 47-52.
11. A.I. Bush, The metallobiology of Alzheimer's disease, Trends in Neurosci 26 (2003), 207-214. Review.
12. R.A. Yokel, Brain uptake, retention, and efflux of aluminum and manganese, Environ Health Perspect 5(Suppl) (2002), 699-704. Review.
13. M. Favarato, P. Zatta, M. Perazzolo, L. Fontana and M. Nicolini, Aluminum(III) influences the permeability of the bloodbrain barrier to [14C]sucrose in rats, Brain Res 569 (1992), 330-335.
14. B.D. Zipser, C.E. Johanson, L. Gonzalez, T.M. Berzin, R. Taveres, C.M. Hulette, M.P. Vitek, V. Hovanesian and E.G. Stopa, Microvascular injury and blood-brain barrier leakage in Alzheimer's disease, Neurobiol Aging (2006), article in press.
15. M. Kawahara, Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases, J Alzheimers Dis 8(2) (2005), 171-182.
16. P. Zatta, Metal Ions and Neurodegenerative Disorders, Singapore, World Scientific, 2003.
17. V. Bala Gupta, S. Anitha, M.L. Hedge, L. Zecca, M.R. Garruto, R. Ravid, S.K. Shankar, R. Stein, P. Shanmugavelu and K.S. Jagannatha Rao, Aluminium in Alzheimer's disease: are we still at a crossroad?, Cell Mol Life Sci 62 (2005), 143-158.
18. F. Ricchelli, R. Buggio, D. Drago, M. Salmona, G. Forloni, A Negro, G. Tognon and P. Zatta, Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann-Straussler-Scheinker disease peptides in the presence of metal ions, Biochemistry 45(21) (2006), 6724-6732.
19. P. Zatta, P. Zambenedetti, V. Bruna and B. Filippi, Activation of acetylcholinesterase by aluminum (III): the relevance of the metal species, NeuroReport 5 (1994), 1777-1780.
20. M.T. Conconi, S. Lora, S. Baiguera, E. Boscolo, M. Folin, R. Scienza, P. Rebuffat, P.P. Parnigotto and G.G. Nussdorfer, In vitro culture of rat neuromicrovascular endothelial cells on polymeric scaffolds, J Biomed Mater Res 71 (2004), 669-674.
21. T. Mossman, Rapid colorimetric assay for cellular growth and survival, application to proliferation and cytotoxicity assays, J Immunol Meth 65 (1983), 55-63.
22. D. Ribatti, D. Guidolin, M.T. Conconi, B. Nico, S. Baiguera, P.P. Parnigotto, A. Vacca and G.G. Nussdorfer, Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo, Oncogene 22 (2003), 6458-6461.
23. S. Baiguera, M.T. Conconi, D. Guidolin, G. Mazzocchi, L.K. Malendowicz, P.P. Parnigotto, R. Spiazzi and G.G. Nussdorfer, Ghrelin inhibits in vitro angiogenic activity of rat brain microvascular endothelial cells, Int J Mol Med 14 (2004), 849-854.
24. H. LeVine, Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution, Protein Sci 2 (1993), 404-410.
25. C.M. Dobson, Experimental investigation of protein folding and Misfolding, Methods 34 (2004), 4-14.
26. K.F. DuBay, A.P. Pawar, F. Chiti, J. Zurdo, C.M. Dobson and M. Vesdruscolo, Prediction of absolute aggregation rates of amyloidogenic polypeptide chains, J Mol Biol 341 (2004), 1317-1326.
27. V.T. Marchesi, An alternative interpretation of the amyloid Aβ hypothesis with regard to the pathogenesis of Alzheimer's disease, Proc Natl Acad Sci USA 102 (2005), 9093-9098.
28. F. Ricchelli, D. Drago, B. Filippi, G. Tognon and P. Zatta, Aluminum-triggered structural modifications and aggregation of β-amyloids, Cell Mol Life Sci 63 (2005), 1724-1733.
29. A. Campbell, M.A. Smith, L.M. Sayre, S.C. Bondy and G. Perry, Mechanisms by which metals promote events connected to neurodegenerative diseases, Brain Res Bull 55 (2001), 125-132.
30. T. Kiss, K. Gajda-Schrantz and P. Zatta, The Role of Aluminium in Neurotoxic and Neurodegenerative Processes, in: Neurodegenerative Diseases and Metal Ions, A. Sigel and H. Sigel, eds., Wiley & Sons, Chichester, 2006, in press.
31. D. Boyd-Kimball, R. Sultana, H. Mohmmad-Abdul and D.A. Butterfield, Rodent Aβ(1-42) exhibits oxidative stress properties similar to those of human Aβ(1-42): implications for proposed mechanisms of toxicity, J Alzheimer Dis 6 (2004), 515-525.
32. T. Dyrks, E. Dyrks, C.L. Masters and K. Beyreuther, Amyloidogenicity of rodent and human βA4 sequences, FEBS Lett 324 (1993), 231-236.
33. E. House, J. Collingwood, A. Khan, O. Korchazkina, G. Berthon and C. Exley, Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta 42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease, J Alzheimer Dis 6 (2004), 291-301.
34. 3, Inorg Chim Acta 171 (1990), 79-83.
35. J. Xu, S. Chen, G. Ku, S:H. Ahmed, J. Xu, H. Chen and C.Y. Hsu, Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation, J Cerebr Blood Flow Metab 21 (2001), 702-710.
36. J.F. Poduslo, G.L. Curran, T.M. Wengenack, B. Malester and K. Duff, Permeability of Proteins at the Blood - Brain Barrier in the Normal Adult Mouse and Double Transgenic Mouse Model of Alzheimer's Disease, Neurobiol Dis 8 (2001), 555-567.
37. F.X. Soriano, J.L. Galbete and G. Forloni, Effect of β-amyloid on endothelial cells: lack of direct toxicity, enhancement of MTT-induced cell death and intracellular accumulation, Neurochem Int 43 (2003), 251-261.
38. M.V. Berridge and A.S. Tan, Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-dipheniltetrazolium bromide (MTT): subcellular localization, substate dependence, and involment of mitochondrial electron transport in MTT reduction, Arch Biochem Biophys 303 (1993), 474-482.
39. M.S. Shearman, C.I. Ragan and L.L. Iversen, Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death, Proc Natl Acad Sci USA 91 (1994), 1470-1474.
40. A.J. Patel, S. Gunasekera, A. Jen and H.A.R. de Silva, β-Amyloid-mediated inhibition of redox activity (MTT reduction) is not an indicator of astroglial degeneration, NeuroReport 7 (1996), 2026-2030.
41. Y. Liu and D. Schubert, Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis, J Neurochem 69 (1997), 2285-2293.
42. P. Kerokoski, H. Soininenm and T. Pirttilam, Beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality, Neurochem Int 38 (2001), 127-134.
43. D. Guidolin, A. Vacca, G. Nussdorfer and D. Ribatti, A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the Matrigel assay in vitro, Microvasc Res 67 (2004), 117-124.
44. A.H. Vagnucci and W.W. Li, Alzheimer's disease and angiogenesis, Lancet 61 (2003), 605-608.
45. T. Miyakawa, Electron microscopy of amyloid fibrils and microvessel, Ann NY Acad Sci 826 (1997), 25-34.
46. F. Liu, B.H. Lau, Q. Peng and V. Shah, Pycnogenol protects vascular endothelial cells from β-amyloid-induced injury, Biol Pham Bull 23 (2000), 735-737.
47. D. Paris, A. Townsend, J. Quadros, J. Humphrey, J. Sun, S. Brem, M. Wotoczek-Obadia, A. DelleDonne, N. Patel, D.F. Obregon, R. Crescentini, L. Abdullah, D. Coppola, A.M. Rojiani, F. Crawford, S.M. Sebsti and M. Mullan, Inhibition of angiogenesis by Aβ peptides, Angiogenesis 7 (2004), 75-85.
48. D. Paris, N. Patel, A. DelleDonne, A. Quadros, R. Smeed and M. Mullan, Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis, Neurosci Lett 366 (2004), 80-85.